Works matching DE "RESPIRATORY syncytial virus infection vaccines"
Results: 221
Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare: Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare: Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
The RSV Vaccine Population was Narrowed for Good Reason, says Robert Hopkins, Jr, MD, Medical Director of the NFID: ACIP recommendations for the most appropriate older population for the RSV vaccine has shifted and the NFID medical director explains why.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Investigational RSV Vaccine Yields Positive Preliminary Data in Head-to-Head Comparison with Arexvy.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
New Data Highlight Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake.
- Published in:
- Patient Care (Online), 2024, p. 4
- By:
- Publication type:
- Article
New Data for Arexvy Show Vaccine Efficacy Through 3 RSV Seasons in Older Adults.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
RSV Mortality Higher than for Influenza B 90 Days After Hospital Discharge: New Data.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
RSV Vaccine Effective Against Hospitalization in Older Adults: Daily Dose.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Co-administration of Arexvy and Shingrix Yields Positive Topline Phase 3 Data, GSK Reports.
- Published in:
- Patient Care (Online), 2024, p. 3
- By:
- Publication type:
- Article
RSV Vaccine Proves 75% Effective Against Hospitalization in Older Adults, According to New CDC Data.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Respiratory Virus Vaccines: A Q&A With AAFP President Steven Furr, MD.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Respiratory Virus Vaccine Update: AAFP Board Chair Details ACIP 2024-25 Recommendations.
- Published in:
- Patient Care (Online), 2024, p. 69
- By:
- Publication type:
- Article
Prenatal RSV Vaccine Not Associated with Preterm Birth, According to First Real-World Data.
- Published in:
- Patient Care (Online), 2024, p. 50
- By:
- Publication type:
- Article
ACIP Revises Recommendation for Adult RSV Vaccination.
- Published in:
- Patient Care (Online), 2024, p. 22
- By:
- Publication type:
- Article
ACIP Recommendations for RSV Vaccines in Older Adults: Update August 2024.
- Published in:
- Patient Care (Online), 2024, p. 25
- Publication type:
- Article
ACIP Revises Recommendation for Adult RSV Vaccination.
- Published in:
- Patient Care (Online), 2024, p. 4
- By:
- Publication type:
- Article
FDA Approves First mRNA Vaccine Against RSV for Adults Aged ≥60 Years: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 2
- Publication type:
- Article
FDA Approves Moderna's mRESVIA, First mRNA Vaccine Against RSV, for Adults Aged ≥60 Years.
- Published in:
- Patient Care (Online), 2024, p. 3
- Publication type:
- Article
Vaccination of Older Adults Against RSV Could Reduce Symptomatic Cases by 1 Million per Year: Modeling Study.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 Results.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies.
- Published in:
- Science Immunology, 2018, v. 3, n. 21, p. 1, doi. 10.1126/sciimmunol.aar3534
- By:
- Publication type:
- Article
Structure based Computational Investigation of Phytocompounds from Vitex Negundo as Drug Candidate for Human Respiratory Syncytial Virus (hRSV).
- Published in:
- Grenze International Journal of Engineering & Technology (GIJET), 2024, v. 10, n. 2,Part 5, p. 6027
- By:
- Publication type:
- Article
Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 97, doi. 10.3390/vaccines13020097
- By:
- Publication type:
- Article
Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 97, doi. 10.3390/vaccines13020097
- By:
- Publication type:
- Article
Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial Virus.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 93, doi. 10.3390/vaccines13010093
- By:
- Publication type:
- Article
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 52, doi. 10.3390/vaccines13010052
- By:
- Publication type:
- Article
Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 26, doi. 10.3390/vaccines13010026
- By:
- Publication type:
- Article
Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1444, doi. 10.3390/vaccines12121444
- By:
- Publication type:
- Article
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1418, doi. 10.3390/vaccines12121418
- By:
- Publication type:
- Article
RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1354, doi. 10.3390/vaccines12121354
- By:
- Publication type:
- Article
A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1351, doi. 10.3390/vaccines12121351
- By:
- Publication type:
- Article
The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1321, doi. 10.3390/vaccines12121321
- By:
- Publication type:
- Article
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1317, doi. 10.3390/vaccines12121317
- By:
- Publication type:
- Article
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1232, doi. 10.3390/vaccines12111232
- By:
- Publication type:
- Article
Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 980, doi. 10.3390/vaccines12090980
- By:
- Publication type:
- Article
Efficacy, Safety, and Immunogenicity of Subunit Respiratory Syncytial Virus Vaccines: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 879, doi. 10.3390/vaccines12080879
- By:
- Publication type:
- Article
The Central Conserved Peptides of Respiratory Syncytial Virus G Protein Enhance the Immune Response to the RSV F Protein in an Adenovirus Vector Vaccine Candidate.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 807, doi. 10.3390/vaccines12070807
- By:
- Publication type:
- Article
KD-409, a Respiratory Syncytial Virus FG Chimeric Protein without the CX3C Chemokine Motif, Is an Efficient Respiratory Syncytial Virus Vaccine Preparation for Passive and Active Immunization in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 753, doi. 10.3390/vaccines12070753
- By:
- Publication type:
- Article
Age-Stratified Seroprevalence of Respiratory Syncytial Virus: Analysis Using Prefusion F and G Protein Antibodies.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 513, doi. 10.3390/vaccines12050513
- By:
- Publication type:
- Article
Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 500, doi. 10.3390/vaccines12050500
- By:
- Publication type:
- Article
Respiratory Syncytial Vaccination: Parents' Willingness to Vaccinate Their Children.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 418, doi. 10.3390/vaccines12040418
- By:
- Publication type:
- Article
Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 294, doi. 10.3390/vaccines12030294
- By:
- Publication type:
- Article
Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1809, doi. 10.3390/vaccines11121809
- By:
- Publication type:
- Article
Respiratory Syncytial Virus: Willingness towards a Future Vaccine among Pregnant Women in Italy.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1691, doi. 10.3390/vaccines11111691
- By:
- Publication type:
- Article
Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1679, doi. 10.3390/vaccines11111679
- By:
- Publication type:
- Article
Reply to Standaert, B. Comment on "Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium".
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1673, doi. 10.3390/vaccines11111673
- By:
- Publication type:
- Article
Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11 , 990.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1646, doi. 10.3390/vaccines11111646
- By:
- Publication type:
- Article